RecruitingNCT06301893

Uganda Sickle Surveillance Study (US-3)

Prevalence and Mapping of Sickle Cell Trait and Disease in Uganda


Sponsor

Children's Hospital Medical Center, Cincinnati

Enrollment

1,000,000 participants

Start Date

Sep 7, 2013

Study Type

OBSERVATIONAL

Conditions

Summary

It is estimated that over 250,000 babies are born with sickle cell disease (SCD) annually in sub-Saharan Africa, and only 10% - 50% of them survive beyond five years of age. Data describing the magnitude of the sickle cell problem are lacking in most African countries. The available data on prevalence were mainly from older studies and small numbers of hospitalized patients. In Uganda, approximately 25,000 children are born with SCD but 70-80% die before their 5th birthday. Lehmann and Raper found 'sicklaemia' prevalence of 0.8% and 45% in the Sebei and Bambaa ethnic groups, respectively. A recent study found a SCT and SCD prevalence of 3% - 19% and 0% - 3%, respectively but this study addressed only 5 of Uganda's 111 districts and used a small convenience sample of children aged 6 - 60 months. The objective of this study is to determine the prevalence and map out the burden of SCT and SCD in Uganda.


Eligibility

Max Age: 12 Months

Inclusion Criteria1

  • Up to 1,000,000 samples may be collected during 2015 - 2030 following primary analysis based on surveillance findings.

Exclusion Criteria1

  • Repeat samples on the same individuals during the study period will be excluded.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(4)

Makerere University

Kampala, Uganda

Minister of Health

Kampala, Uganda

National Coordinator EID Program

Kampala, Uganda

Sickle Cell Clinic Department of Pediatrics & Child Health Mulago Hospital

Kampala, Uganda

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06301893


Related Trials